Last updated on August 2019

Viral Conjunctivitis Treatment Study

Brief description of study

The objective of this study is to determine the efficacy Avenova (0.01% hypochlorous acid) in the treatment of viral conjunctivitis. The investigators hypothesize that patients treated with Avenova will have a quicker resolution of their ocular signs and symptoms of Viral Conjunctivitis compared with artificial tears.

Detailed Study Description

Avenova is a proprietary pure hypochlorous acid under a family of skin cleansing products by NovaBay that has been cleared by the FDA as a 510(k) medical device. Many in vitro studies have evaluated the efficacy of hypochlorous acid against microbacterial and viral agents. In ophthalmology, it is commonly used as a lid cleanser in the treatment of blepharitis and meibomian gland dysfunction. It is applied directly to the lid margin and has an excellent skin and ocular safety profile, which includes a lack of ocular irritation on application.The investigators propose a study to evaluate the role of Avenova (0.01% hypochlorous acid) in the treatment of common ocular viral infections.

Clinical Study Identifier: NCT03861728

Find a site near you

Start Over